102 results on '"Schwarz, Sally W."'
Search Results
2. Future cancer research priorities in the USA: a Lancet Oncology Commission
3. Contributors
4. The Regulatory Process for Imaging Agents and Devices
5. Beyond FDG: Novel Radiotracers for PET Imaging of Melanoma and Sarcoma
6. Radioimmunotherapy with a 64Cu-Labeled Monoclonal Antibody: A Comparison with 67Cu
7. US and EU radiopharmaceutical diagnostic and therapeutic nonclinical study requirements for clinical trials authorizations and marketing authorizations
8. Proceedings: PET Drugs—A Workshop on Inspections Management and Regulatory Considerations
9. The Development of 18F Fluorthanatrace: A PET Radiotracer for Imaging Poly (ADP-Ribose) Polymerase-1
10. Radiopharmacy: regulations and legislations in relation to human applications
11. Radiolabeled Antibodies: Introduction and Metal Conjugation Techniques
12. Chapter 83 - The Regulatory Process for Imaging Agents and Devices
13. Dosimetry of 60/61/62/64Cu-ATSM: a hypoxia imaging agent for PET
14. Global Issues of Radiopharmaceutical Access and Availability: A Nuclear Medicine Global Initiative Project
15. Imaging Myocardium Enzymatic Pathways with Carbon-11 Radiotracers
16. Immunoscintigraphy with a new indium-111-labeled monoclonal antibody (MAb 1A3) in patients with colorectal cancer
17. Nuclear medicine and positron emission tomography: an overview
18. Harmonization of U.S., European Union, and Canadian First-in-Human Regulatory Requirements for Radiopharmaceuticals: Is This Possible?
19. Perspective on How the FDA Should Review Diagnostic Radiopharmaceuticals
20. USP Public Standards for Compounded Sterile Radiopharmaceuticals: Recommendations from SNMMI
21. Harmonization of U.S., European Union, and Canadian First-in-Human Regulatory Requirements for Radiopharmaceuticals: Is This Possible?
22. [ 18 F]FHBG PET/CT Imaging of CD34-TK75 Transduced Donor T Cells in Relapsed Allogeneic Stem Cell Transplant Patients: Safety and Feasibility
23. The Role of Exploratory Investigational New Drugs for Translating Radiopharmaceuticals into First-in-Human Studies
24. Regulatory Requirements for PET Drug Production
25. Diversification in the Supply Chain of 99Mo Ensures a Future for 99mTc
26. Challenges for Developing PET Tracers: Isotopes, Chemistry, and Regulatory Aspects
27. Diversification in the Supply Chain of 99Mo Ensures a Future for 99mTc.
28. Dosimetry of 60/61/62/64Cu-ATSM: a hypoxia imaging agent for PET.
29. 64Cu-TETA-Octreotide as a PET Imaging Agent for Patients with Neuroendocrine Tumors.
30. Radiotherapy, Toxicity and Dosimetry of Copper-64-TETA-Octreotide in Tumor-Bearing Rats.
31. Dosimetry of Copper-64-Labeled Monoclonal Antibody 1A3 as Determined by PET Imaging of the Torso.
32. RadioimmunoPET: Detection of Colorectal Carcinoma with Positron-Emitting Copper-64-Labeled Monoclonal Antibody.
33. Preparation, Biodistribution and Dosimetry of Copper-64-Labeled Anti-Colorectal Carcinoma Monoclonal Antibody Fragments 1A3-F(ab')2.
34. Copper-64-Labeled Antibodies for PET Imaging.
35. An Exciting Time for Nuclear Medicine and Molecular Imaging.
36. Collaborative Endeavors.
37. Preparing the Next Generation of Nuclear Medicine Professionals.
38. FDA Approval of Imaging Agents: An Exciting Investment in Nuclear Medicine.
39. Quality Systems Personnel Training Program for Radiopharmaceutical Manufacturing.
40. From the SNM Committee on Pharmacopeia.
41. Final PET CGMP Regulation.
42. Ensuring a Safe, Reliable Supply of 99Mo/99mTc.
43. Working Together to Advance Women in Nuclear Medicine.
44. Working Together to Advance Nuclear Medicine and Molecular Imaging.
45. From the SNM Committee on Pharmacopeia.
46. Evaluation of a direct method for technetium labeling intact and F(ab′) 2 1A3, an anticolorectal monoclonal antibody
47. [18F]FHBG PET/CT Imaging of CD34-TK75 Transduced Donor T Cells in Relapsed Allogeneic Stem Cell Transplant Patients: Safety and Feasibility.
48. Proceedings: PET Drugs-A Workshop on Inspections Management and Regulatory Considerations.
49. The Development of 18 F Fluorthanatrace: A PET Radiotracer for Imaging Poly (ADP-Ribose) Polymerase-1.
50. Global Issues of Radiopharmaceutical Access and Availability: A Nuclear Medicine Global Initiative Project.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.